A first-of-its-kind clinical trial found that ketamine’s benefits for treating severe depression can be improved when combined with psychotherapy and supportive treatment environments.

Led by researchers at McGill University, the study suggests this approach can yield valuable therapeutic experiences that lead to longer-lasting relief than standard treatment.

The study enrolled patients with chronic, treatment-resistant depression, most of which were experiencing suicidal thoughts and struggling with other mental health conditions.